Cargando…

Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetes

OBJECTIVE: The objective of this study was to assess the association between clinically indicated liraglutide treatment and coronary artery plaque progression during 1-year follow-up in asymptomatic diabetes. METHODS: Patients were divided into a group receiving liraglutide (Lira+) and a group not r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinsen, Laurits Juhl, Pararajasingam, Gokulan, Andersen, Thomas Rueskov, Auscher, Søren, Sheta, Hussam Mahmoud, Precht, Helle, Engdam, Kalle Brunebjerg, Hangaard, Jørgen, Lambrechtsen, Jess, Knop, Filip Krag, Egstrup, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148401/ https://www.ncbi.nlm.nih.gov/pubmed/37118678 http://dx.doi.org/10.1186/s12872-023-03228-5

Ejemplares similares

High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score
por: Heinsen, Laurits Juhl, et al.
Publicado: (2021)

Diabetic microvascular complications are associated with reduced global longitudinal strain independent of atherosclerotic coronary artery disease in asymptomatic patients with diabetes mellitus: a cross-sectional study
por: Pararajasingam, Gokulan, et al.
Publicado: (2021)

Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up
por: Pararajasingam, Gokulan, et al.
Publicado: (2019)

The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients
por: Biesenbach, Irmelin I. A., et al.
Publicado: (2023)

Can prediabetes diagnosed using HemoglobinA1c or oral glucose tolerance test predict presence and severity of coronary artery disease in symptomatic patients?
por: Overgaard, Katrine S, et al.
Publicado: (2023)

Influence of adaptive statistical iterative reconstruction algorithm on image quality in coronary computed tomography angiography
por: Precht, Helle, et al.
Publicado: (2016)

Is There Any Improvement in Image Quality in Obese Patients When Using a New X-ray Tube and Deep Learning Image Reconstruction in Coronary Computed Tomography Angiography?
por: Pfeffer, Anne-Sofie Brunebjerg, et al.
Publicado: (2022)

Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea
por: Kårhus, Martin Lund, et al.
Publicado: (2022)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

Liraglutide and Glycaemic Outcomes in the LEADER Trial
por: Zinman, Bernard, et al.
Publicado: (2018)

Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption
por: Kårhus, Martin Lund, et al.
Publicado: (2021)

The association between diabetes and abdominal aortic aneurysms in men: results of two Danish screening studies, a systematic review, and a meta-analysis of population-based screening studies
por: Larsen, Katrine Lawaetz, et al.
Publicado: (2023)

Survival, Prevalence, Progression and Repair of Abdominal Aortic Aneurysms: Results from Three Randomised Controlled Screening Trials Over Three Decades
por: Lindholt, Jes S, et al.
Publicado: (2020)

Association of Left Atrial Size Measured by Non-Contrast Computed Tomography with Cardiovascular Risk Factors—The Danish Cardiovascular Screening Trial (DANCAVAS)
por: Fredgart, Maise Høigaard, et al.
Publicado: (2022)

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study
por: Dejgaard, Thomas Fremming, et al.
Publicado: (2015)

The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial
por: Diederichsen, Axel Cosmus Pyndt, et al.
Publicado: (2015)

On necessary and sufficient conditions for L^{p}-estimates of Riesz transforms associated to elliptic operators on {R}^{n} and related estimates
por: Auscher, Pascal
Publicado: (2007)

Liraglutide – Indian Experience
por: Anirban, Majumder, et al.
Publicado: (2018)

Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021)

Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial
por: Gudbergsen, Henrik, et al.
Publicado: (2019)

Why diversity among participants in clinical studies is not always preferable: the case for small, exploratory studies
por: Ellegaard, Anne-Marie, et al.
Publicado: (2023)

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
por: Zhao, Xu, et al.
Publicado: (2019)

Focused sonographic examination of the heart, lungs and deep veins in acute admitted patients with respiratory symptoms
por: Laursen, Christian B, et al.
Publicado: (2012)

A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
por: Andersen, Andreas, et al.
Publicado: (2021)

Non-diabetic use of liraglutide
por: Verma, Abhyudaya
Publicado: (2012)

Liraglutide-induced Acute Gastroparesis
por: Rai, Puja, et al.
Publicado: (2018)

Monotherapy with liraglutide – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity
por: Nexøe‐Larsen, Christina C., et al.
Publicado: (2018)

Effects of menaquinone-7 supplementation in patients with aortic valve calcification: study protocol for a randomised controlled trial
por: Lindholt, Jes Sanddal, et al.
Publicado: (2018)

Elliptic boundary value problems with fractional regularity data: the first order approach
por: Amenta, Alex, et al.
Publicado: (2018)

Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density
por: Chen, Kai, et al.
Publicado: (2021)

Patient-rated level of discomfort during assessment with point-of-care ultrasonography
por: Laursen, Christian B, et al.
Publicado: (2015)

Hepatic microbiome in healthy lean and obese humans
por: Suppli, Malte Palm, et al.
Publicado: (2021)

Mitral Annulus Calcification and Cardiac Conduction Disturbances: A DANCAVAS Sub-study
por: Rasmussen, Jeppe Holm, et al.
Publicado: (2022)

Managing insulin resistance: role of liraglutide
por: Kalra, Sanjay, et al.
Publicado: (2010)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

An accidental liraglutide overdose: case report
por: Elmehdawi, Rafik R., et al.
Publicado: (2014)

Liraglutide: another reason to target prediabetes?
por: Murphy, Conor F., et al.
Publicado: (2017)

Role of liraglutide in Alzheimer’s disease pathology
por: Vargas-Soria, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_emm6vielq4hga71q6472q818ds